ProShare Advisors’s Avalo Therapeutics AVTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-4
| Closed | -$8K | – | 1820 |
|
|
2022
Q1 | $8K | Sell |
4
-1
| -20% | -$2K | ﹤0.01% | 2195 |
|
|
2021
Q4 | $22K | Buy |
+5
| New | +$22K | ﹤0.01% | 2329 |
|
|
2021
Q3 | – | Sell |
-5
| Closed | -$45K | – | 2026 |
|
|
2021
Q2 | $45K | Buy |
5
+1
| +25% | +$9K | ﹤0.01% | 2363 |
|
|
2021
Q1 | $35K | Buy |
+4
| New | +$35K | ﹤0.01% | 2246 |
|